Gonadotropin releasing hormone antagonists and cryopreservation outcome: A review

被引：3
作者：
Nikolettos N. [1 ]
Asimakopoulos B. [1 ]
Simopoulou M. [1 ]
Al-Hasani S. [2 ]
Diedrich K. [2 ]
机构：
[1] Lab. of Reproductive Physiology-IVF, Faculty of Medicine, Democritus University of Thrace, 68100 Dragana, Alexandroupolis
[2] Department of Obstetrics, Medical University Lübeck, 23538 Lübeck
来源：
Archives of Gynecology and Obstetrics | 2004年 / 270卷 / 2期
关键词：
Cryopreservation; GnRH-agonist; GnRH-antagonist; In-vitro fertilisation;
D O I：
10.1007/s00404-003-0597-3
中图分类号：
学科分类号：
摘要：
Review: The outcome of freeze-thaw cycles with pronuclear stage oocytes or embryos, derived from collecting cycles stimulated with gonadotropin-releasing hormone (GnRH)-antagonists' protocols, was reviewed. Conclusion: The viability of cryopreserved pronuclear stage oocytes and embryos, the quality of transferred embryos and the pregnancy rates of the freeze-thaw cycles seem to be satisfactory regardless of the type and dose of GnRH-antagonist.
引用
收藏
页码：69 / 73
页数：4
相关论文
共 52 条
[1]  
Albano C., Smitz J., Camus M., Riethmuller-Winzen H., Van Steirteghem A.C., Devroey P., Comparison of different doses of gonadotrophin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation, Fertil Steril, 67, pp. 917-922, (1997)
[2]  
Albano C., Felberbaum R.E., Smitz J., Riethmuller-Winzen H., Engel J., Diedrich K., Devroey P., Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist Cetrorelix and the LHRH-agonist buserelin, Hum Reprod, 15, pp. 526-531, (2000)
[3]  
Al-Inany H., Aboulghar M., GnRH antagonist in assisted reproduction: A Cochrane review, Hum Reprod, 17, pp. 874-885, (2002)
[4]  
Asimakopoulos B., Nikolettos N., Al-Hasani S., Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist Cetrorelix, Reprod Biomed Online, 5, SUPPL. 1, pp. 52-56, (2002)
[5]  
Asimakopoulos B., Nikolettos N., Al-Hasani S., Diedrich K., An evaluation of the multiple dose protocol of Cetrorelix in single ovary women, In Vivo, 17, pp. 89-92, (2003)
[6]  
Brus L., Lambalk C.B., De Koning J., Helder M.N., Janssens R.M.J., Schoemaker J., Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles, Hum Reprod, 12, pp. 769-773, (1997)
[7]  
Casan E.M., Raga F., Bonilla-Musoles F., Polan M.L., Human oviductal gonadotropin-releasing hormone: Possible implications in fertilization, early embryonic development and implantation, J Clin Endocrinol Metab, 85, pp. 1377-1381, (2000)
[8]  
Das K., Stout D., Hensleigh H.C., Tagatz G.E., Phipps W.R., Leung B.S., Direct positive effect of EGF on the cytoplasmic maturation of mouse and human oocytes, Fertil Steril, 55, pp. 1000-1004, (1991)
[9]  
Dekel N., Sherizly I., Epidermal growth factor induces maturation of rat follicle-enclosed oocytes, Endocrinology, 116, pp. 406-409, (1985)
[10]  
Dekel N., Lewysohn O., Ayalon D., Hazum E., Receptor for GnRH are present in rat oocytes, Endocrinology, 123, pp. 1205-1207, (1988)
123456